SCHEMBL30482281

SCHEMBL30482281

CCn1c(=O)n(Cc2ccccc2C(F)(F)F)c(=O)c2c(-c3cc(O)cnc3C(N)=O)cccc21

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.40
▸ GNRHR P30968 2/20 0.39
▸ PLK1 P53350 1/20 0.38
▸ RORC P51449 1/20 0.37
▸ KIF11 P52732 5/20 0.37
▸ CYP2C9 P11712 4/20 0.37
▸ SCD O00767 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TNKS O95271 2/20 0.35
▸ TNKS2 Q9H2K2 2/20 0.35
▸ HSD17B13 Q7Z5P4 2/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ CMA1 P23946 1/20 0.35
▸ C5AR1 P21730 1/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ PPARG P37231 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30482379 0.81 HSD17B13 (0.39) TDP1GNRHRPLK1KIF11SCD
SCHEMBL30482332 0.75 TDP1 (0.45) TDP1GNRHRCYP2C9TNKSTNKS2
SCHEMBL31227314 0.73 TDP1 (0.45) TDP1GNRHRCYP2C9TNKSTNKS2
SCHEMBL25431431 0.72 TP53 (0.47) TDP1CYP2C9LMNATP53MAPT
SCHEMBL30482287 0.69 LMNA (0.46) TDP1CYP2C9LMNATP53MAPT
SCHEMBL26228669 0.69 HSD17B13 (0.68) HSD17B13
SCHEMBL6692824 0.64 AURKA (0.43) TDP1RORCKIF11CYP2C9SCD
SCHEMBL6780469 0.64 CYP3A4 (0.41) TDP1RORCKIF11CYP2C9C5AR1
SCHEMBL6774832 0.63 CD38 (0.44) TDP1RORCKIF11CYP2C9C5AR1
SCHEMBL6782082 0.63 RORC (0.42) TDP1RORCKIF11CYP2C9EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469451-A1 2-SUBSTITUTED THIAZOLE HSD17B13 INHIBITORS AND USES THEREOF Inipharm, Inc. (US) 2024-12-04 — — EP disclosed
WO-2023146897-A1 2-SUBSTITUTED THIAZOLE HSD17B13 INHIBITORS AND USES THEREOF INIPHARM, INC. (US) 2023-08-03 — — WO disclosed
Send feedback